Exited company
MethylGene Inc.
Investor
![Phil Anzarut]()
About the company
MethylGene is a biopharmaceutical company focused on the discovery, development and commercialization of novel and proprietary enzyme inhibitors for the treatment of cancer and infectious diseases.